CONTEXT: Results from the analysis of registry involving around 6,000 TAVR patients in the US.
IMPACT: Low
READ TIME: 2 mins
Quality Level Mean [1 – 10]: 6
1. “(TVT) Registry was presented today during the EuroPCR 2021 late-breaking clinical trials hotline session by Raj Makkar, M. D. , Director, Interventional Cardiology, Associate Director, Smidt Heart Institute at Cedars Sinai Medical Center. “”
2. “The propensity-matched analysis comparing real-world data of bicuspid and tricuspid AS patients collected from the Society of Thoracic Surgeons and American College of Cardiology (STS/ACC)”
3. “Transcatheter Valve Therapy”
4. “In addition to the excellent survival and stroke rates, outcomes data from the TVT Registry also demonstrated a low rate of significant paravalvular leak, as well as significant and similar improvements in functional status and quality of life measures.”